Gucopyranosyloxy-octyl-pyridiniumaldoxime-Cpd13c
General
Type : Glycosylated-oxime, Pyridine-aldoxime, Oxime
Chemical_Nomenclature : N-[(3-beta-d-glucopyranosyloxy)octyl]-2-pyridiniumaldoxime chloride
Canonical SMILES : [C@@H]1(C([C@@H]([C@@H](OC1CO)OCCCCCCCC[N+]2=C(C=CC=C2)C=NO)O)O)O.[Cl-]
InChI : InChI=1S\/C20H32N2O7.ClH\/c23-14-16-17(24)18(25)19(26)20(29-16)28-12-8-4-2-1-3-6-10-22-11-7-5-9-15(22)13-21-27\;\/h5,7,9,11,13,16-20,23-26H,1-4,6,8,10,12,14H2\;1H\/t16?,17-,18?,19+,20-\;\/m1.\/s1
InChIKey : UDLPFCUAODUTDY-SRPJKDFNSA-N
Other name(s) : Compound 13c || GluOct2POx
Target
Structure : No structure
Families : No family
References (1)
| Title : Novel oximes as blood-brain barrier penetrating cholinesterase reactivators - Garcia_2010_Chem.Biol.Interact_187_199 |
| Author(s) : Garcia GE , Campbell AJ , Olson J , Moorad-Doctor D , Morthole VI |
| Ref : Chemico-Biological Interactions , 187 :199 , 2010 |
| Abstract : |
| PubMedSearch : Garcia_2010_Chem.Biol.Interact_187_199 |
| PubMedID: 20227398 |